Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Covington
Chinese Patent Office
UBS
Queensland Health
Fuji
QuintilesIMS
Cerilliant

Generated: May 24, 2018

DrugPatentWatch Database Preview

EUTRON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Eutron patents expire, and when can generic versions of Eutron launch?

Eutron is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in EUTRON is methyclothiazide; pargyline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the methyclothiazide; pargyline hydrochloride profile page.
Summary for EUTRON
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 49
Formulation / Manufacturing:see details
DailyMed Link:EUTRON at DailyMed
Drug patent expirations by year for EUTRON
Synonyms for EUTRON
2-12-00-00548 (Beilstein Handbook Reference)
2-Propynylamine, N-benzyl-N-methyl-
4CH-018729
555-57-7
9MV14S8G3E
A 19120
AB00053516
AB00053516_13
AC1L1IQA
AC1Q3X8K
AC1Q3X8L
AI3-62058
AK139344
AKOS009027469
BDBM50172756
Benzenemethanamine, N-methyl-N-2-propynyl-
Benzyl-methyl-2-propinylamin
Benzyl-methyl-2-propinylamin [Czech]
Benzyl-methyl-prop-2-ynyl-amine
benzyl(methyl)(prop-2-yn-1-yl)amine
BENZYLAMINE, N-METHYL-N-2-PROPYNYL-
Benzylmethylpropargylamine
Benzylmethylpropynylamine
BPBio1_000117
BRD-K83597974-003-05-7
BRN 1938132
BSPBio_000105
BSPBio_002159
C07414
C11H13N
CAS-306-07-0
CBChromo1_000308
CCG-205102
CCRIS 6740
CHEBI:7930
CHEMBL673
CS-4685
CTK8G1951
D08453
D0R0UJ
DB-072009
DB01626
DivK1c_000053
DPWPWRLQFGFJFI-UHFFFAOYSA-
DPWPWRLQFGFJFI-UHFFFAOYSA-N
DTXSID3023423
EINECS 209-101-6
Eudatin
Eutonyl
Eutonyl (Salt/Mix)
FT-0700064
GTPL7262
HMS3604I04
HY-A0091A
I14-93520
IDI1_000053
InChI=1/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3
KB-79507
KBio1_000053
KBio2_001121
KBio2_003689
KBio2_006257
KBio3_001659
KBioGR_000918
KBioSS_001121
Lopac-P-8013
Lopac0_001022
LS-43403
M2618
MCULE-3540521287
methylbenzylprop-2-ynylamine
Methylbenzylpropynylamine
MO 911
MO-911
MolPort-001-792-188
N-benzyl-N-methyl-2-propinylamine
N-Benzyl-N-methyl-2-propyn-1
N-Benzyl-N-methyl-2-propyn-1-amine
N-Benzyl-N-methyl-2-propyn-1-amine #
N-Benzyl-N-methyl-2-propynylamine
N-benzyl-N-methyl-prop-2-yn-1-amine
N-benzyl-N-methylprop-2-yn-1-amine
N-Methyl-N-(2-propyn-1-yl)benzylamine
N-Methyl-N-(2-propynyl)benzylamine-
N-methyl-N-(phenylmethyl)prop-2-yn-1-amine
N-methyl-N-2-propyn-1-yl-Benzenemethanamine
N-Methyl-N-2-propynylbenzylamine
N-Methyl-N-benzylpropynylamine
N-methyl-N-propargyl benzyl amine
N-Methyl-N-propargylbenzylamine
N-Methyl-N-propargylbenzylamine, 97%
NCGC00015841-01
NCGC00015841-02
NCGC00015841-03
NCGC00015841-04
NCGC00015841-05
NCGC00015841-06
NCGC00015841-07
NCGC00024240-03
NINDS_000053
NSC43798
OR012743
OR284283
Paragyline
Pargilina
Pargilina [INN-Spanish]
Pargylamine
Pargylin
pargyline
Pargyline (INN)
Pargyline [INN:BAN]
Pargyline chloride
Pargyline hydrochloride (Salt/Mix)
Pargylinum
Pargylinum [INN-Latin]
Prestwick0_000183
Prestwick1_000183
Prestwick2_000183
Prestwick3_000183
SBB037855
SBI-0050995.P004
SCHEMBL2045
SPBio_001257
SPBio_002026
Spectrum_000641
Spectrum2_001039
Spectrum3_000540
Spectrum4_000469
Spectrum5_001030
ST079278
ST2407429
Supirdyl
UNII-9MV14S8G3E
W-105554
ZINC53084618

US Patents and Regulatory Information for EUTRON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott EUTRON methyclothiazide; pargyline hydrochloride TABLET;ORAL 016047-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
US Army
Queensland Health
Harvard Business School
Cipla
Accenture
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.